Skip to main content Skip to search Skip to main navigation

About PepMix™ HSV1 (gD)

PepMix™ HSV1 (gD) is an HSV-1 glycoprotein D peptide pool for antigen-specific T-cell stimulation. Its 96 overlapping peptides span the gD sequence of strain KOS (UniProt A1Z0Q5), using 15-mers with an 11-amino-acid overlap. The pool supports cellular immune-response studies directed at this defined HSV-1 envelope antigen

Pool of 96 peptides derived from a peptide scan (15mers with 11 aa overlap) through Envelope protein (Swiss-Prot ID: A1Z0Q5) of Herpes Simplex Virus - HHV-1 (strain KOS).

PepMix™ HSV1 (gD) - Specifications

  • Amount: 25 µg (approx. 15 nmol) / peptide (for stimulation of up to 2,5 x 108 cells)
  • Purity: Development Grade: each peptide purified to > 70% (HPLC/MS) - (equivalent to an average purity of 85%)
  • Delivery Format: Freeze-dried in glass vial
  • Application(s): T-cell Immunity
  • Condition(s)/Topic(s): Cancer, Encephalitis, Genital herpes, Oral Herpes, Infection
  • Standard Delivery Time: 2-5 days

Applications

  • Assessment of HSV-1 gD-reactive T-cell responses by ELISpot
  • Intracellular cytokine staining (ICS) following gD peptide stimulation
  • Immune monitoring of responses to HSV-1 glycoprotein D

Are you interested in your own custom PepMix? Choose your sequence, amount, purity and pool format. We will assist you along the way. Custom PepMix Peptide Pools.

HSV-1 gD Peptides for Infectious Disease Research

Within JPT’s PepMix™ Peptide Pools for Infectious Disease Antigens, this PepMix focuses on glycoprotein D from HSV-1 strain KOS. It provides a defined antigen stimulus for herpes simplex T-cell studies in which the viral type and source strain need to be documented. The HSV-1 identity distinguishes this pool from the separately available HSV-2 gD product.

Overlapping Coverage of HSV-1 Glycoprotein D

The 96-peptide scan brings multiple regions of KOS gD into one pooled reagent, avoiding the need to select a single epitope before initial T-cell screening. Each peptide is supplied at Development Grade purity above 70% by HPLC/MS, with a defined amount per peptide for assay preparation.

Need individual HSV-1 sequences for follow-up studies?
Explore JPT Custom Peptide Synthesis for project-specific peptide requirements after pooled antigen screening.

References for PepMix™ HSV1 (gD)

References
Read References with
PepMix™ Peptide Pools for Infectious Diseases
COVID-19 related PepMixes™
PepMix™ Control Pools

Application Notes
Cross-reactive T cells enhance immune responses in SARS-CoV-2 infection and vaccination
Loyal et al (2021) Full text
Peptide Tools to Support the Fight against COVID-19
Alem et al (2020) Full text
CEFX/EFX Ultra SuperStim Pools: Superior positive controls for T-cell assays with broad MHC-allele and antigen coverage
Eckey et al. (2017) Full text
Developing Multi-HIV Antigen Specific T-Cells as a Component of a Cure Strategy
Lam et al. (2015) Full text
Peptide-stimulated Expansion of Virus-specific T cells For Preventative Treatment After Allogeneic Stem Cell Transplantation
Gary et al. (2015) Full text
PepMix™ Peptide Pools for Clinical Applications: T Cell Therapy for Viral Infections after Hematopoietic Stem Cell Transplant
Keirnan et al. (2012) Full text
Cytomegalovirus Protein Spanning PepMix™ Peptide Pools to Discover Changes in T-Cell Immunity in the Aging Population
Kern (2012) Full text

Testimonials
"To establish a novel role for myeloid derived suppressor cells (Pallett et al, Nat. Med. 2015) in chronic viral infection, we utilised the PepMix CEF Pool (extended) as well as a custom synthesized PepMix spanning the core region of HBV genotype D . Whereas, the CEF peptide pool consists of 32 peptides, each corresponding to a defined HLA class I-restricted T-cell epitope from Cytomegalo, Epstein-Barr, and Influenza virus, the latter custom PepMix included 15meric peptides overlapping by 10 amino acids. Specifically this composition enabled us to monitor both the antiviral CD8+ and CD4+ T cell responses in chronic HBV infection and the non-antigen specific T cells that are known to mediate immunopathology in the liver. Our entire experience with JPT, from ordering/delivery to use in the lab was excellent. Not only were the reagents able to perform reliably and consistently in vitro from batch to batch, the customer and technical support provided was continually available and efficient when needed. JPT will remain our go-to company for purchasing peptides."
Dr. Laura J Pallett, Infection and Immunity, University College London, UK

Documentation for PepMix™ HSV1 (gD)

Properties of PepMix™ HSV1 (gD)

Amount: 25 µg (approx. 15 nmol) / peptide (for stimulation of up to 2,5 x 108 cells)
Application: T-cell immunity
Category: PepMix Peptide Pools
Condition / Topic: Cancer, Encephalitis, Genital herpes, Infection, Oral Herpes
Layout: Freeze-dried in glass vial
Organism: Herpes Simplex Virus
Protein Name: Envelope protein
Purity: Development Grade: each peptide purified to > 70% (HPLC/MS)
Quantification: No

Further Information to PepMix™ HSV1 (gD)

Information Values
Sequence:
MGGAAARLGAVILFVVIVGLHGVRGKYALADASLKMADPNRFRGKDLPVLDQLTDPPGVRRVYHIQAGLPDPFQPPSLPITVYYAVLERACRSVLLNAPSEAPQIVRGASEDVRKQPYNLTIAWFRMGGNCAIPITVMEYTECSYNKSLGACPIRTQPRWNYYDSFSAVSEDNLGFLMHAPAFETAGTYLRLVKINDWTEITQFILEHRAKGSCKYALPLRIPPSACLSPQAYQQGVTVDSIGMLPRFIPENQRTVAVYSLKIAGWHGPKAPYTSTLLPPELSETPNATQPELAPEDPEDSALLEDPVGTVAPQIPPNWHIPSIQDAATPYHPPATPNNMGLIAGAVGGSLLAALVICGIVYWMHRRTRKAPKRIRLPHIREDDQPSSHQPLFY
Specifications: Peptide scan (15mers with 11 aa overlap)
Loading...

Check our list of products, click and go.

Get a quote